SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : RXSD Rexall Sundown -- Ignore unavailable to you. Want to Upgrade?


To: LAWRENCE C. who wrote (200)12/7/1998 10:37:00 PM
From: Adelantado  Read Replies (1) | Respond to of 327
 
Yet, with this news Zacks analysis report a 35 % rise in EPS over same quarter last year. Seems to me that while private brands are common in large chains such as Wal-Mart, they rarely encroach in more than a few percentages of market share.

As to mis-representations of earning: these have to be intentional and for unlawful purposes. Reviewing insider trading over the last 6 months I don't see anyone making a bundle from the inaccurate forcasts last April. And we all know that every company has the problem of correctly forcasting earnings into the future, just like we do. Furthermore, the business of RXSD, its customer base, its mangagement, its cost of doing business, etc are still in place and the same as they were last year notwithstanding Wal-Mart placing house labled products alongside well-known Rexall.

As I see it, market over-reacted. The superflague of class-action law-suits will be joined by some district court a few months later. A few sets of interrogatories will be filed. A few attempts to negotiate a settlement will occure. Meanwhile, the price of stock will recover as money managers fear that they won't have time to get in while the price is rock bottom. At some point, last month's news will become history and the on-lookers will wonder why they didn't jump in at 11 1/4.

So, it takes 6 months to double, what's the problem?

Joe